Concourse Financial Group Securities, Inc. Invo Bioscience, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share
Q2 2023 Aug 10, 2023	BUY	$0.16 - $0.64 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.44 - $0.81 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.39 - $28.0 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.77 - $23.2 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.64 - $2.66 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.19 - $3.82 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.93 - $4.19 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.17 - $4.61 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.18 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.96 - $9.4 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.0 - $9.47 $0 - $0

Others Institutions Holding INVO

# of Institutions

Shares Held

14.1K

Call Options Held

Put Options Held

Eidelman Virant Capital

14.1K
Shares

$11,249
0.01% of portfolio

View Full List

About INVO Bioscience, Inc.

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $9.74M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

More about INVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account